Published in:
01-04-2020 | Correction
Correction to: Induced membrane maintains its osteogenic properties even when the second stage of Masquelet’s technique is performed later
Published in: European Journal of Trauma and Emergency Surgery | Issue 2/2020
Login to get accessExcerpt
The original version of this article unfortunately contained a mistake. The presentation and legends of Figs. 4 and 5 were incorrect. The corrected versions are given below. The original article has been corrected.
Fig. 4
Immunolabelling of IMs sampled at the time of the second procedure: 4 months for patient (P) 13 (4a, d, g, j), 13.5 months for P24 (4b, e, h, k) and 14.7 months for P25 (4c, f, i, l): anti-human Ki67 (4a, b, c), anti-human alpha-smooth muscle actin (αSMA) (4d, e, f), anti-human collagen IV (Col IV) (4g, h, i) and anti-human fibronectin (4j, k, l). Blood vessels are indicated by arrows (diagonal upward arrow). Outermost zone (oz) and innermost zone (iz) are visible
Fig. 5
Immunolabelling specific to cartilage in IMs sampled at the time of the second procedure: 4 months for patient (P) 13 (5a, d, g), 13.5 months for P24 (5b, e, h) and 14.7 months for P25 (5c, f, i): anti-human collagen II (Col II) (5a, b, c) and anti-human aggrecan (5d, e, f), and Safranin O staining (5g, h, i). Outermost zone (oz) and innermost zone (iz) are visible
× ![]()
× ![]()
…